Drug Profile
Ganstigmine
Alternative Names: CHF 2819Latest Information Update: 03 Aug 2004
Price :
$50
*
At a glance
- Originator Chiesi
- Class Alkaloids; Carbamates; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 03 Aug 2004 Discontinued - Phase-II for Alzheimer's disease in France (PO)
- 03 Aug 2004 Discontinued - Phase-II for Alzheimer's disease in Italy (PO)
- 03 Aug 2004 Discontinued - Phase-II for Alzheimer's disease in USA (PO)